MENU

CME Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom CME on January 29, 2025, netting in a 3.14% gain over 2 weeks

A.I.dvisor
at Tickeron.com
Loading...
+3.14% Gain from a Successful pattern Head-and-Shoulders Bottom
CME - CME Group
Tickeron
Ticker: CME
Company: CME Group
Gain: +3.14%
Confirmed: 01/29/25
Succeeded: 02/11/25
Total length: 14 days
On January 28, 2025, A.I.dvisor detected a Head-and-Shoulders Bottom Pattern (Bullish) for CME Group (CME, $234.39). On January 29, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $250.60. 13 days later, on February 11, 2025, CME reached the target price resulting in a for traders who took a long position in the stock.

CME's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CME turned positive on January 22, 2025. Looking at past instances where CME's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 22, 2025. You may want to consider a long position or call options on CME as a result. In of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CME moved above its 50-day moving average on January 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 251 cases where CME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CME moved out of overbought territory on February 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where CME's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CME broke above its upper Bollinger Band on February 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.855) is normal, around the industry mean (5.562). P/E Ratio (23.930) is within average values for comparable stocks, (34.442). CME's Projected Growth (PEG Ratio) (8.558) is very high in comparison to the industry average of (2.610). Dividend Yield (0.041) settles around the average of (0.030) among similar stocks. P/S Ratio (13.661) is also within normal values, averaging (113.078).

View a ticker or compare two or three
CME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of securities and commodity exchanges

Industry InvestmentBanksBrokers

Profile
Fundamentals
Details
Industry
Investment Banks Or Brokers
Address
20 South Wacker Drive
Phone
+1 312 930-1000
Employees
3565
Web
https://www.cmegroup.com